Pharmaceutical giant Abbott Laboratories (ABT) delivered a 12% increase in third-quarter revenue to $7.7 billion, helped by a 43% increase in diagnostics product sales. The top line surpassed market consensus, which was projected at $7.67 billion. However, net income from continuing operations fell to $563 million or 31 cents per share, compared to $603 million, … Continue reading Abbott posts strong Q3 results, narrows full year outlook